BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Neuspera Medical Receives FDA Approval for First Integrated Sacral Neuromodulation (iSNM) System for Urinary Urge Incontinence

  June 18, 2025

   · 

  3 min read
• Press Releases

  FDA’s Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients

  June 18, 2025

   · 

  5 min read
• Press Releases

  Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

  June 18, 2025

   · 

  4 min read
• Press Releases

  Exosomes Skincare Market to Reach USD 809.5 Billion by 2032 Driven by Advancements in Anti-Aging and Cell Therapy Solutions

  June 18, 2025

   · 

  1 min read
• Press Releases

  Moolec Science Secures Core U.S. Patent for Piggy Sooy(TM), Soybean Expressing Up to 30% of Animal Protein

  June 18, 2025

   · 

  2 min read
• Press Releases

  Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study

  June 18, 2025

   · 

  5 min read
• Press Releases

  AbbVie Announces New Data Demonstrating Atogepant (QULIPTA® / AQUIPTA®) Achieves Superiority Across All Endpoints in Phase 3 Head-to-Head Study Compared to Topiramate for Migraine Prevention

  June 18, 2025

   · 

  10 min read
• Press Releases

  Phare Bio Wins Newsweek’s AI Impact Award for “Most Innovative Technology or Service”

  June 18, 2025

   · 

  2 min read
• Press Releases

  Health Canada approves Novartis’ KISQALI® for HR+/HER2- early breast cancer patients at high risk of recurrence

  June 18, 2025

   · 

  11 min read
• Press Releases

  Outlook Therapeutics to Participate in a Virtual Investor Lunch Break Event

  June 18, 2025

   · 

  1 min read